New anti-resistant antibiotic – piperacillin sodium and sulbactum sodium for injection (2:1)
- At: 2007 FIP Congress in Beijing (China)
- Type: Poster
- By: HUANG, Huimin (Welman Pharm R&D Centre, Guangzhou, China)
- Co-author(s): Sun, Mingjie (Welman Pharm R&D Centre, GUANGZHOU, China)
Lv, Huachong (Guangdong Pharmaceutical College, GUANGZHOU, China)
Wang, Ting (Welman Pharm R&D Centre, GUANGZHOU, China)
The pharmacologic action and clinical trial results of 'piperacillin sodium and sulbactum sodium (PIP/SBT) for injection (2:1)' were reviewed in this article. Methods: The therapeutic effect of PIP/SBT was confirmed by pharmacologic and antibiosis experiments in vitro and in vivo, tolerance and pharmacokinetics experiment with volunteer and.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.